|Net Assets||1.20 Bil|
- Last NAV update 12/4/2013 4:00 PM ET
|The investment seeks capital appreciation. The fund invests mainly in common stocks (growth or value stocks or both) of large and midsize companies worldwide that the manager believes have favorable investment potential. Potential investments include companies that manufacture health care supplies or provide health care-related services, and companies in the research, development, production and marketing of pharmaceuticals and biotechnology products. It may also use derivatives, and may engage in short sales of securities. The fund is non-diversified.|
- Year to date performance as of 12/4/2013 12:00 AM ET
|Fund Manager||Kelsey Chen|
|Minimum Initial Purchase||0.00|
|Minimum IRA Investment||NA|
- * Annualized returns
- Performance as of 12/4/2013 12:00 AM ET
|Net Assets||1.20 Bil||693.18 Mil|
|Avg Market Cap||35.90 Bil||24.01 Bil|
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.